DoW Duchenne Muscular Dystrophy, Clinical/Translational Research Award
Funds preclinical or clinical Duchenne muscular dystrophy research, at a smaller or a larger funding level.
Duchenne muscular dystrophy research has a long list of promising leads and a much shorter list that ever reaches a clinic. This award funds pushing further down that list, toward something a patient could actually receive.
It funds advanced translational research — preclinical or clinical — that accelerates a promising DMD idea toward clinical application, addressing at least one FY26 CTRA Focus…
Advanced preclinical or clinical translational Duchenne muscular dystrophy research at Funding Level 1 or Level 2, addressing at least one FY26 CTRA Focus Area and informing the development of drugs, devices and other interventions, including pilot clinical trials and trial-readiness studies. Preliminary data are required.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up